Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Biosensors in Medical Diagnostics Continue Steady Growth

By HospiMedica staff writers
Posted on 26 Jan 2007
The biosensor industry has evolved continuously in the past few years and is expected to maintain steady growth in the future.

University and industrial researchers have been consistently working toward numerous developments, which are giving shape to new biosensor platforms for pain-free, accurate, and selectively sensitive developments of diagnostic biosensors, said the Frost and Sullivan (Palo Alto, CA, USA) analyst of the study. More...
As the whole concept of biosensors is based on the basic principles of science such as physics, chemistry, and biology, there are a wide range of factors which one can manipulate to develop a novel and more efficient sensor or technology platform.

The success of biosensors lies in the fact that it has become the inevitable choice as a cost-effective diagnostic tool. With time, more people have come to accept biosensors as the potential medical device that has the capability to render efficient, easy-to-use, yet accurate diagnosis. Hence, as doctors look forward to alternative easier and simpler techniques for diagnosis and patients prepare to accept simpler, cost-effective techniques, the field of biosensing has apparently received the best impetus toward growth.

Globally, the number of people requiring medical attention is increasing primarily due to the inclement population explosion. Moreover, people are succumbing to variegated ailments due to their unhealthy day-to-day practices or occupational hazards. This increase in the number of patients is the vital reason behind the boost in the biosensor industry. Moreover, biosensors have proved themselves to be useful for a wide range of applications in the field of medical ailment detection as well as analytical diagnosis.

From the diagnosis of acute conditions such as cancer and blood glucose monitoring, the exigency of an efficient, compatible, and user-friendly biosensor is imperative. Due to increasing demand, biosensors are experiencing rapid growth in the industry as compared to any other medical device or instrument. The reason behind its proliferation lies in the fact that it gives researchers and companies exciting challenges to overcome, explained the analyst. The mechanism of action behind present-day industrial sensors as well as new technologies is being exhaustively worked upon for the development of more effective biosensors.



Related Links:
Frost and Sullivan

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.